Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006. The company was founded as the Serono Pharmacological Institute by Cesare Serono in 1906 in Rome, Italy.
A key step in its development was the discovery of a method of extracting urinary gonadotropins by Dr. Piero Donini. Serono was incorporated in 1987 and the holding company, Ares-Serono S.A., changed its name to Serono S.A. in May 2000.
Serono develops and markets pharmaceuticals in the fields of reproductive health, multiple sclerosis, growth & metabolism and dermatology.[1]
The eight biotechnology products are available in four core therapeutic areas: neurology for the treatment of relapsing forms of multiple sclerosis, reproductive health for treatments of infertility, dermatology, where Serono has launched biologics in Europe for moderate-to-severe psoriasis, and
growth and metabolism for treatments for HIV-associated wasting and growth deficiencies.
The company also conducts research in oncology and autoimmune diseases. Through the acquisition in 1997 of GBRI from GlaxoWelcome, becoming its Geneva based research institute named SPRI, and the Manteia Predictive Medicine spin-off, Serono also nursed the emergence of now a commercial leading massive parallel sequencing technology.
^"Serono 2000 Sales Up 15.2%". Evaluate Group. 23 January 2001. Retrieved 23 June 2018.
Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006. The company...
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of...
billion for Serono SA, Switzerland's largest biotech firm. The deal included a buy-out of the Bertarelli family's 64.5% stake in Serono to be followed...
MBA at Harvard Business School in 1993. His grandfather, Pietro, joined Serono, a pharmaceutical company founded in 1906. In 1935 Pietro became the company's...
Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting. In...
pharmaceutical and life sciences company founded in 1668 Merck Serono (known as EMD Serono in the United States and Canada), a pharmaceutical company headquartered...
sciences de la vie recrutent à Genève grâce à des ex-employés de Merck Serono", Le Temps, Tuesday 21 April 2015, page 13. (in French) Health Valley Archived...
Puerto Rico Plant". justice.gov. 26 October 2010. Retrieved 25 August 2012. "Serono to Pay $704 Million for the Illegal Marketing of AIDS Drug". justice.gov...
"Compugen, Merck Serono set up biomarkers JV". Globes. 25 June 2012. Retrieved 2018-01-07. "Metabomed, ChanBio join Merck Serono Israel Bioincubator"...
acquired by Serono of Switzerland in 2002, now part of Merck Serono.[citation needed] In 2006, Merck launched a takeover bid for Serono. Genset: 1989...
Seattle-based biotech company, ZymoGenetics, which handed the product over to Merck Serono for further development. Hartung HP, Kieseier BC (July 2010). "Atacicept:...
former Merck Serono building, in Geneva (Switzerland). The Campus Biotech is a part of the Swiss Innovation Park. End of June 2013, Merck Serono left its...
United States Bertarelli Ernesto Bertarelli, Dona Bertarelli 17.4 (2024) Serono Italy Switzerland Kuok Robert Kuok 16.6 (2017) Kuok Group Malaysia Meijer...
improve lives. The Center is based at Campus Biotech (in the former Merck Serono building) located in Geneva, Switzerland. The CEO of the Wyss Center is...
Bertarelli an Italian-Swiss businessman who was the owner of biotech giant Serono until 2007 and winner of the America's Cup in 2003 and 2007 with his yachting...
injection) for Subcutaneous Use. U.S. Full Prescribing Information" (PDF). EMD Serono, Inc. Archived from the original (PDF) on 18 December 2011. Retrieved 9...
Fabio Bertarelli. She and her brother Ernesto inherited Serono, a biotechnology company. Serono was founded in 1906 in Rome and was the building block...
Humatrope (Lilly), Genotropin (Pfizer), Norditropin (Novo), and Saizen (Merck Serono). In 2006, the U.S. Food and Drug Administration (FDA) approved a version...
Glucophage (Metformin), for type 2 diabetes mellitus, marketed by EMD Serono. Insuman (Human insulin), for type 1 and type 2 diabetes mellitus. Lantus...
in 2000, and partnered with Serono in 2002. Ivax was acquired by Teva in 2006, and Merck KGaA acquired control of Serono's drug business in 2006. An oral...
Global Information
